XML 40 R30.htm IDEA: XBRL DOCUMENT
v3.23.2

Summary of Significant Accounting Policies - Additional Information (Detail) | 6 Months Ended
--- | ---
Jun. 30, 2023
Anelixis Therapeutics, LLC and Otic Pharma, Ltd. |
Summary Of Significant Accounting Policies [Line Items] |
Ownership interest percentage | 100.00%
Otic Pharma, Inc. [Member] |
Summary Of Significant Accounting Policies [Line Items] |
Ownership interest percentage | 100.00%

X
- Definition Summary of significant accounting policies. + References No definition available. + Details
Name: | eldn_SummaryOfSignificantAccountingPoliciesLineItems
Namespace Prefix: | eldn_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Percentage of subsidiary's or equity method investee's stock owned by parent immediately after all stock transactions. + References No definition available. + Details
Name: | us-gaap_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactions
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=eldn_AnelixisTherapeuticsLlcAndOticPharmaLtdMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dei_LegalEntityAxis=eldn_OticPharmaIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |